MedTrace Logo

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

NCT01992250 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-04-20

No results posted yet for this study

Summary

This study examines the use of cryoablation as an alternative to surgery in the treatment of early stage invasive breast cancer. The hypothesis is that cryoablation will complete ablation and destroy the tumor in a selected population of women who may otherwise be adequately treated with surgery.

Conditions

Interventions

DEVICE

Visica 2 Treatment System

Cryoablation

Sponsors & Collaborators

  • Sanarus Technologies, Inc.

    lead INDUSTRY

Principal Investigators

  • Dennis R. Holmes, MD, FACS · 90210 Surgery Medical Center

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2021-12-31
Completion
2023-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01992250 on ClinicalTrials.gov